assessment of the anti-SARS-CoV-2 IgG antibody titer in 2-dose schedule
Sponsors
Collegium Medicum w Bydgoszczy
Conditions
SARS-CoV2 AntibodiesSARS-CoV2 Infection
Unknown Phase
Determinants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination Study
NCT05109585
Start: 2021-04-20End: 2022-12-31Target: 1000Updated: 2021-11-05
Determinants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination Study in Patients After Organ Transplantation
NCT05162456
Start: 2021-07-01End: 2023-04-30Target: 250Updated: 2021-12-17